Cargando…
Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980557/ https://www.ncbi.nlm.nih.gov/pubmed/26979130 http://dx.doi.org/10.1038/leu.2016.41 |
| _version_ | 1782447475433406464 |
|---|---|
| author | Freeman, C L Dixon, M Houghton, R Kreuzer, K-A Fingerle-Rowson, G Herling, M Humphrey, K Böttcher, S de Costa, C S Iglesias, V Stilgenbauer, S Gribben, J Hallek, M Goede, V |
| author_facet | Freeman, C L Dixon, M Houghton, R Kreuzer, K-A Fingerle-Rowson, G Herling, M Humphrey, K Böttcher, S de Costa, C S Iglesias, V Stilgenbauer, S Gribben, J Hallek, M Goede, V |
| author_sort | Freeman, C L |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4980557 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-49805572016-08-24 Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab Freeman, C L Dixon, M Houghton, R Kreuzer, K-A Fingerle-Rowson, G Herling, M Humphrey, K Böttcher, S de Costa, C S Iglesias, V Stilgenbauer, S Gribben, J Hallek, M Goede, V Leukemia Letter to the Editor Nature Publishing Group 2016-08 2016-04-08 /pmc/articles/PMC4980557/ /pubmed/26979130 http://dx.doi.org/10.1038/leu.2016.41 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| spellingShingle | Letter to the Editor Freeman, C L Dixon, M Houghton, R Kreuzer, K-A Fingerle-Rowson, G Herling, M Humphrey, K Böttcher, S de Costa, C S Iglesias, V Stilgenbauer, S Gribben, J Hallek, M Goede, V Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab |
| title | Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab |
| title_full | Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab |
| title_fullStr | Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab |
| title_full_unstemmed | Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab |
| title_short | Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab |
| title_sort | role of cd20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with cll treated with obinutuzumab |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980557/ https://www.ncbi.nlm.nih.gov/pubmed/26979130 http://dx.doi.org/10.1038/leu.2016.41 |
| work_keys_str_mv | AT freemancl roleofcd20expressionandotherpretreatmentriskfactorsinthedevelopmentofinfusionrelatedreactionsinpatientswithclltreatedwithobinutuzumab AT dixonm roleofcd20expressionandotherpretreatmentriskfactorsinthedevelopmentofinfusionrelatedreactionsinpatientswithclltreatedwithobinutuzumab AT houghtonr roleofcd20expressionandotherpretreatmentriskfactorsinthedevelopmentofinfusionrelatedreactionsinpatientswithclltreatedwithobinutuzumab AT kreuzerka roleofcd20expressionandotherpretreatmentriskfactorsinthedevelopmentofinfusionrelatedreactionsinpatientswithclltreatedwithobinutuzumab AT fingerlerowsong roleofcd20expressionandotherpretreatmentriskfactorsinthedevelopmentofinfusionrelatedreactionsinpatientswithclltreatedwithobinutuzumab AT herlingm roleofcd20expressionandotherpretreatmentriskfactorsinthedevelopmentofinfusionrelatedreactionsinpatientswithclltreatedwithobinutuzumab AT humphreyk roleofcd20expressionandotherpretreatmentriskfactorsinthedevelopmentofinfusionrelatedreactionsinpatientswithclltreatedwithobinutuzumab AT bottchers roleofcd20expressionandotherpretreatmentriskfactorsinthedevelopmentofinfusionrelatedreactionsinpatientswithclltreatedwithobinutuzumab AT decostacs roleofcd20expressionandotherpretreatmentriskfactorsinthedevelopmentofinfusionrelatedreactionsinpatientswithclltreatedwithobinutuzumab AT iglesiasv roleofcd20expressionandotherpretreatmentriskfactorsinthedevelopmentofinfusionrelatedreactionsinpatientswithclltreatedwithobinutuzumab AT stilgenbauers roleofcd20expressionandotherpretreatmentriskfactorsinthedevelopmentofinfusionrelatedreactionsinpatientswithclltreatedwithobinutuzumab AT gribbenj roleofcd20expressionandotherpretreatmentriskfactorsinthedevelopmentofinfusionrelatedreactionsinpatientswithclltreatedwithobinutuzumab AT hallekm roleofcd20expressionandotherpretreatmentriskfactorsinthedevelopmentofinfusionrelatedreactionsinpatientswithclltreatedwithobinutuzumab AT goedev roleofcd20expressionandotherpretreatmentriskfactorsinthedevelopmentofinfusionrelatedreactionsinpatientswithclltreatedwithobinutuzumab |